Hawaii SCR 8: REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.

Status: Reported from HLT (Stand. Com. Rep. No. 2071), recommending referral to FIN. (as of 2025-04-14)

State: Hawaii · Session: 2025 · Bill: SCR 8

Subjects: Auditor, Health, Insurance, Ketamine Therapy, Medicaid, Report

Sponsors: FEVELLA

View Hawaii SCR 8 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.